Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Molecular Pharmaceutics|June 27, 2022
Synthesis and Evaluation of Novel 111In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic PlatformShimpei Iikuni, Yuta Tarumizu, Shohei Tsuchihashi, et al.Journal of Medicinal Chemistry|September 3, 2021
Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane AntigenShimpei Iikuni, Yuta Tarumizu, Kazuma Nakashima, et al.ACS Medicinal Chemistry Letters|February 19, 2021
Structure-Activity and Brain Kinetics Relationships of 18F-Labeled Benzimidazopyridine Derivatives as Tau PET TracersHiroyuki Watanabe, Yuta Tarumizu, Sho Kaide, et al.Molecular Pharmaceutics|November 30, 2024
Novel Radiotheranostic Ligands Targeting Prostate-Specific Membrane Antigen Based on Dual Linker ApproachNobuki Kazuta, Kazuma Nakashima, Yuta Tarumizu, et al.ACS Medicinal Chemistry Letters|May 31, 2021
Characterization and Optimization of Benzimidazopyrimidine and Pyridoimidazopyridine Derivatives as Tau-SPECT ProbesHiroyuki Watanabe, Takeaki Kishimoto, Sho Kaide, et al.Journal of Medicinal Chemistry|June 7, 2023
Development of NovelShohei Tsuchihashi, Kazuma Nakashima, Yuta Tarumizu, et al.Journal of Medicinal Chemistry|May 13, 2025
Development of Novel Radiotheranostic Ligand with Positively Charged Unit Targeting Prostate-Specific Membrane AntigenTakuma Hasegawa, Kazuma Nakashima, Yuta Tarumizu, et al.Pageof 1